Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma

Liver cancer–secreted serine protease inhibitor Kazal (LC-SPIK) is a protein that is specifically elevated in cases of hepatocellular carcinoma (HCC). We assessed the performance of LC-SPIK in detecting HCC, including its early stages, in patients with cirrhosis, hepatitis B virus (HBV), and hepatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Felix, Shah, Pir Ahmad, Rao, Abhishek, Gifford-Hollingsworth, Cynthia, Chen, Anne, Trey, Gary, Soryal, Mina, Talat, Arslan, Aslam, Aysha, Nasir, Bilal, Choudhry, Saad, Ishtiaq, Rizwan, Sanoff, Hanna, Conteh, Lanla F., Noonan, Anne, Hu, Ke-Qin, Schmidt, Carl, Fu, Min, Civan, Jesse, Xiao, Gary, Lau, Daryl T.-Y., Lu, Xuanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685967/
https://www.ncbi.nlm.nih.gov/pubmed/33512798
http://dx.doi.org/10.14309/ctg.0000000000000271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685967/
https://www.ncbi.nlm.nih.gov/pubmed/33512798
http://dx.doi.org/10.14309/ctg.0000000000000271

Ejemplares similares